Contemporary perspectives on the genetics and clinical use of lipoprotein(a) in preventive cardiology-Reference-Cited by-同舟云学术

Contemporary perspectives on the genetics and clinical use of lipoprotein(a) in preventive cardiology

Published:2021-03-17 Issue:3 Volume:36 Page:272-280
ISSN:0268-4705
Container-title:Current Opinion in Cardiology
language:en
Short-container-title:

Author:

Page Michael M.,Watts Gerald F.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine

Reference72 articles.

1. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines;Grundy;Circulation,2019

2. Physicochemical properties of apolipoprotein(a) and lipoprotein(a-) derived from the dissociation of human plasma lipoprotein (a);Fless;J Biol Chem,1986

3. Structure, function, and genetics of lipoprotein (a);Schmidt;J Lipid Res,2016

4. Structure-function relationships in apolipoprotein(a): insights into lipoprotein(a) assembly and pathogenicity;Koschinsky;Curr Opin Lipidol,2004

5. Oxidized phospholipids as a unifying theory for lipoprotein(a) and cardiovascular disease;Boffa;Nat Rev Cardiol,2019

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Apolipoprotein(a) production and clearance are associated with plasma IL-6 and IL-18 levels, dependent on ethnicity;Atherosclerosis;2024-04

2. The ins and outs of lipoprotein(a) assay methods;Archives of Medical Science – Atherosclerotic Diseases;2024-01-03

3. State of current management of the heightened risk for atherosclerotic cardiovascular events in an established cohort of patients with lupus erythematosus;Lupus Science & Medicine;2023-08

4. Lipoprotein (a) variability is associated with mean follow-up C-reactive protein in patients with coronary artery disease following percutaneous coronary intervention;World Journal of Clinical Cases;2022-12-16

5. THE STATE OF CURRENT MANAGEMENT OF THE HEIGHTENED RISK FOR ATHEROSCLEROTIC CARDIOVASCULAR EVENTS IN AN ESTABLISHED COHORT OF PATIENTS WITH LUPUS ERYTHEMATOSUS;2022-12-13